Download video

Immunotherapy-Chemo Offers Survival Advantage in Low PD-L1 NSCLC - Medpage Today

156 views

MedPage Today

3 years ago

Immunotherapy-Chemo Offers Survival Advantage in Low PD-L1 NSCLC - Medpage Today

Immunotherapy-Chemo Offers Survival Advantage in Low PD-L1 NSCLC - Medpage Today

Immunotherapy-Chemo Offers Survival Advantage in Low PD-L1 NSCLC - Medpage Today
1:21
Immunotherapy-Chemo Offers Survival Advantage in Low PD-L1 NSCLC - Medpage Today
by MedPage Today
What Did We Learn From IMpower010 in Resectable NSCLC? - Medpage Today
21:02
What Did We Learn From IMpower010 in Resectable NSCLC? - Medpage Today
by MedPage Today
Is Immunotherapy Combo a Better Option in Advanced NSCLC? - Medpage Today
4:58
Is Immunotherapy Combo a Better Option in Advanced NSCLC? - Medpage Today
by MedPage Today
Is Disease-Free Survival a Meaningful Endpoint in NSCLC? - Medpage Today
4:44
Is Disease-Free Survival a Meaningful Endpoint in NSCLC? - Medpage Today
by MedPage Today
Chemo-IO Over IO Alone in Patients With Advanced NSCLC - Medpage Today
11:09
Chemo-IO Over IO Alone in Patients With Advanced NSCLC - Medpage Today
by MedPage Today
Lung Cancer Video Library - Das - Treatments - Low or Negative PDL1 and Advanced Non-Squamous NSCLC
7:43
Lung Cancer Video Library - Das - Treatments - Low or Negative PDL1 and Advanced Non-Squamous NSCLC
by GRACE - Global Resource for Advancing Cancer Education
NSCLC Treatment: Low PD-L1 Status and Chemotherapy
4:16
NSCLC Treatment: Low PD-L1 Status and Chemotherapy
by AJMCtv
ESMO: First-Line Erlotinib Improves NSCLC Outcomes
3:01
ESMO: First-Line Erlotinib Improves NSCLC Outcomes
by MedPage Today
Who benefits from immunotherapy in patients with advanced ESCC?
1:58
Who benefits from immunotherapy in patients with advanced ESCC?
by VJOncology
The role of Immunotherapy in stage IV NSCLC (PDL1 high\/low)Dr. Julian Molina Day 2
21:39
The role of Immunotherapy in stage IV NSCLC (PDL1 high\/low)Dr. Julian Molina Day 2
by Oncology Events
Dr. Desai on Immunotherapy in Patients With NSCLC and Low PD-L1 Expression
1:42
Dr. Desai on Immunotherapy in Patients With NSCLC and Low PD-L1 Expression
by OncLive
ASCO Roundtable: Lung Cancer Highlights - Medpage Today
15:32
ASCO Roundtable: Lung Cancer Highlights - Medpage Today
by MedPage Today
IMpower133: Real-World vs Clinical Trial Data in SCLC - Medpage Today
3:42
IMpower133: Real-World vs Clinical Trial Data in SCLC - Medpage Today
by MedPage Today
Outcomes of first-line pembrolizumab monotherapy for PD-L1–positive metastatic NSCLC
7:31
Outcomes of first-line pembrolizumab monotherapy for PD-L1–positive metastatic NSCLC
by Video Journal of Biomedicine
First-line Treatment Selection in Metastatic Lung Cancer - Medpage Today
4:18
First-line Treatment Selection in Metastatic Lung Cancer - Medpage Today
by MedPage Today
ASCO: Erbitux Gives Extra Time to Advanced Lung Cancer
3:59
ASCO: Erbitux Gives Extra Time to Advanced Lung Cancer
by MedPage Today
No OS Benefit With Lurbinectedin\/Doxorubicin in SCLC - Medpage Today
2:15
No OS Benefit With Lurbinectedin\/Doxorubicin in SCLC - Medpage Today
by MedPage Today
Early Palliative Care Boosts Survival in NSCLC
3:12
Early Palliative Care Boosts Survival in NSCLC
by MedPage Today
MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC - Medpage Today
3:39
MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC - Medpage Today
by MedPage Today
ADAURA: Extremely Positive Data in Early NSCLC, but Questions Remain - Medpage Today
6:05
ADAURA: Extremely Positive Data in Early NSCLC, but Questions Remain - Medpage Today
by MedPage Today